Clinical Data and Appropriate Patients for Treatment with Vabysmo

In this corporate webinar sponsored by Genentech, a panel of experts focus on dual pathway inhibiting Vabysmo for patients with age-related macular degeneration and diabetic macular edema.

Disclaimer: This corporate webinar was sponsored by Genentech. All content was developed and presenters chosen by the corporate sponsor. 

The Academy does not recommend or endorse any specific advice, tests, drugs, devices, products, services, physicians, or medical institutions that may be mentioned or referenced in the program.